Progress of the “Molecular Informatics” Section in 2022

This is the first Editorial of the "Molecular Informatics" Section (MIS) of the International Journal of Molecular Sciences (IJMS), which was created towards the end of 2018 (the first article was submitted on 27 September 2018) and has experienced significant growth from 2018 to now [...].


State of the Art
This is the first Editorial of the "Molecular Informatics" Section (MIS) of the International Journal of Molecular Sciences (IJMS), which was created towards the end of 2018 (the first article was submitted on 27 September 2018) and has experienced significant growth from 2018 to now. This section focuses on applying computational methods and information technology to understand molecular systems and their interactions.
In 2019, the MIS published 132 articles; by 2022, the number of published articles had more than doubled to 291. One of the key drivers of this growth has been the recent growth and development of new computational tools and methods for analyzing large datasets. For example, machine learning algorithms have been increasingly used in molecular informatics to predict the properties of molecules and understand their interactions with other molecules; molecular docking simulations, one of the key approaches of virtual screening, have been integrated with machine learning techniques to accelerate and enhance the screening process. Another notable achievement in this progress is the development of deep learning methods used to predict the activity of molecules in drug discovery. Deep learning has enabled the identification of more promising drug candidates with a higher probability of achieving clinical success by predicting the bioactivity of molecules at an unprecedented scale. These tools have allowed researchers to analyze vast amounts of data and identify patterns that would be difficult to detect through traditional experimental methods. Moreover, with the development of cloud computing platforms and the availability of powerful supercomputers, researchers can now perform complex simulations and analyses that were once impossible. Overall, the growth of MIS highlights the increasing importance of computational methods in molecular sciences. As these methods continue to advance, they are likely to play an increasingly critical role in understanding biological systems and developing new therapeutics and treatments.
From 2018, the journal impact factor (JIF) of IJMS grew from 4183 to 6208, with an increase of just over 48%, placing the journal in the first quartile of the Biochemistry & Molecular Biology category and the second quartile of the Multidisciplinary Chemistry category. As befits a high-level journal, this growth has rightly translated into a better and more restricted selection of the articles published in terms of quality and novelty.
The Editorial Board (EB) plays a critical role in ensuring the quality and transparency of the publication process for academic articles. The board oversees all stages of the publication process, from initial submission to final publication, and ensures that the highest standards are met.
One of the primary roles of the EB is to ensure that all submissions undergo a rigorous pre-check process to ensure they meet the journal's submission criteria. This filter was mainly operated by the pre-check decisions of the Academic Editors (AEs), who selected articles in terms of quality and relevance to the aims and scope of the journal and, in particular, of the MIS. Moreover, the work of the AEs includes checking that the submission is original, has not been published elsewhere, and meets the required formatting and style guidelines. The guidelines of IJMS also encourage AEs to conduct an initial review of the submission to determine its potential suitability for publication. Once a submission has passed the pre-check process, the EB, always supported by the AEs, is responsible for selecting appropriate reviewers to assess the submission's scientific quality and relevance. The board may consult with external experts to identify suitable reviewers and consider the author's suggestions for potential reviewers. The EB is essential in ensuring the review process is transparent and fair. Reviewers are typically blinded to the author's identity and the identity of other reviewers. The board is also responsible for ensuring reviewers provide constructive, respectful, and helpful feedback to the author.
To collect high-quality research articles in all fields of molecular informatics applied to the understanding of the intricate world of biology and molecular research, the Topical Collection, "Feature Papers in Molecular Informatics", was created, and, looking only at 2022, 25 papers were published . The most recent developments in computer science applied to molecular modeling have been discussed as hot topics in the two collections entitled "State-of-the-Art Molecular Informatics in Italy", which was closed at the end of 2022 [26][27][28][29][30][31][32][33], and "Latest Review Papers in Molecular Informatics 2023", which was closed at the end of February 2023 [34,35]. In 2022, the number of closed SIs was 22, and the top SI based on the number of published articles and visualizations was the one dedicated to "Deep Learning and Machine Learning in Bioinformatics" . We also saw many publications on COVID-19 and SARS-CoV-2, with 49 papers published on this topic between 2020 and 2023 [2,10,12,.
Finally, it is noteworthy to mention the five papers that have received more than one hundred citations since the birth of the MIS:

Future Prospects
The field of molecular informatics is expected to see significant progress in 2023. With the increasing availability of molecular data, advances in machine learning and artificial intelligence tools are expected to enable more accurate predictions of molecular behavior and improved drug discovery processes. Additionally, the development of blockchain technology is expected to provide a secure, decentralized system for managing and sharing molecular data, facilitating collaborations, and accelerating research. Integrating molecular informatics with other fields, such as genomics and proteomics, is also expected to lead to innovative approaches in healthcare, personalized medicine, and drug development. It is an exciting time for the field of molecular informatics, and we can expect to see many new breakthroughs in 2023.
Despite this progress, there is still much to be achieved regarding the MIS; personally, and with the help of the entire Editorial Team (ET), in 2023, I will strive to improve the scientific quality, performance, number of publications, and visibility of the MIS as well as the JIF of IJMS by pursuing the development of the following points:

1.
Encourage high-quality submissions: Ensure the journal clearly focuses on molecular informatics and that the published research meets high standards of originality, scientific rigor, and relevance to the field. This could be achieved by issuing a call for papers to solicit high-quality submissions and inviting leading researchers to submit manuscripts to the journal.

2.
Increase the quality of published papers: The journal must implement a more rigorous peer-review process that includes multiple rounds of review by subject matter experts to improve the quality of published papers. Additionally, the journal could provide more detailed feedback to authors on areas for improvement to help them enhance the quality of their work. Another possibility may be using a double-blind review process to ensure further fairness.

3.
Increase collaboration and interdisciplinary research: Encourage collaboration between molecular scientists, computer scientists, mathematicians, and bioinformaticians. This will promote interdisciplinary research to advance the field and increase the journal's impact. Additionally, establish collaborative partnerships with relevant conferences, research organizations, and societies to increase visibility and reach within the research community.

4.
Provide strong editorial guidance: The journal should have a solid ET to guide and mentor authors and reviewers. This involves identifying areas where the journal should focus, providing clear review criteria, and maintaining high publishing standards.

5.
Encourage open access at low costs: Open-access publishing is the future of scientific publishing, providing greater visibility and ensuring that research reaches a broader audience. Authors could be encouraged to submit to open-access journals through waiver policies, sponsorships, or partnerships with funding agencies. 6.
Prioritize quality over quantity: While increasing the number of publications is essential, it should not come at the expense of quality. Prioritize quality over quantity to maintain the journal's reputation and impact. 7.
Increase the number of publications: The journal could consider publishing more Special Issues or thematic series on topics related to the MIS to increase the number of publications. This could attract a broader range of authors and readers and encourage more submissions. 8.
Increase visibility: The AE could promote the MIS through targeted marketing and social media campaigns to increase the journal's visibility. Additionally, the journal could consider partnering with relevant scientific societies or organizations to promote the journal and its contents. 9.
Increase impact factor: The editor could aim to attract high-quality research that has the potential to be cited by other researchers in the field. 10. Foster a strong community: The journal could host regular webinars, virtual conferences, or networking events focused on topics related to molecular informatics to build a strong community of authors and readers. This could help foster collaboration, knowledge-sharing, and innovation in the field.
In conclusion, great strides have been made in the progress of the MIS, which are crucial to improving IJMS. This progress of IJMS is mainly due to the proper functioning of the entire ET responsible for ensuring transparency and keeping all parties informed of the status of each submission. This includes regularly updating the author on the submission's progress, encouraging reviewers to provide their feedback and decision timely, and making the publication process straightforward and transparent; this is what we will focus on, starting now, in the future.
With the growing focus on using artificial intelligence and machine learning in molecular computing research, further advances should automatically occur in the coming years.